Elekta AB (OTCMKTS:EKTAY – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $6.63, but opened at $5.83. Elekta shares last traded at $5.7020, with a volume of 4,045 shares.
Elekta Stock Performance
The firm has a market capitalization of $2.12 billion, a P/E ratio of -35.96 and a beta of 1.01. The stock has a fifty day simple moving average of $6.01 and a two-hundred day simple moving average of $5.99. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.95 and a quick ratio of 0.73.
Elekta (OTCMKTS:EKTAY – Get Free Report) last issued its earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The business had revenue of $521.00 million during the quarter. Elekta had a positive return on equity of 10.67% and a negative net margin of 3.32%. On average, research analysts predict that Elekta AB will post 0.44 EPS for the current year.
About Elekta
Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.
The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.
See Also
- Five stocks we like better than Elekta
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.
